1.A Pediatric Case of Toxic Hepatitis Induced by Hovenia Dulcis.
Yun Ji KIM ; Seung Lok RYU ; Jae Won SHIM ; Duk Soo KIM ; Jung Yeon SHIM ; Moon Soo PARK ; Hye Lim JUNG
Pediatric Gastroenterology, Hepatology & Nutrition 2012;15(2):111-116
Toxic hepatitis is a rare but devastating disease in children. Herbs are widely used in oriental medicine to treat various symptoms in Korea, however, several herbs have been reported to induce liver injury. We report a case of toxic hepatitis induced by Hovenia dulcis in a 3-year-old boy. He complained of nausea, abdominal discomfort, and jaundice. The patient had consumed water boiled with hovenia dulcis for about 1 year prior to presentation. A diagnosis of toxic hepatitis was made based on his history, laboratory data, viral markers, ultrasonography, and biopsied liver tissue. We administered supportive management for acute fulminant hepatitis but his symptoms and liver function progressed. He was transferred to another hospital for further evaluation and consideration for liver transplantation. Because acute liver failure due to herbs or dietary supplement taken for a long time is often fetal, it is important to make early diagnosis and stop taking the drug as soon as drug induced liver injury is suspected.
Biomarkers
;
Child
;
Dietary Supplements
;
Drug-Induced Liver Injury
;
Early Diagnosis
;
Hepatitis
;
Humans
;
Jaundice
;
Korea
;
Liver
;
Liver Failure, Acute
;
Liver Transplantation
;
Medicine, East Asian Traditional
;
Nausea
;
Preschool Child
;
Water
2.Expression of peroxisome proliferator-activated receptor (PPAR)-alpha and PPAR-gamma in the lung tissue of obese mice and the effect of rosiglitazone on proinflammatory cytokine expressions in the lung tissue.
Seung Lok RYU ; Jae Won SHIM ; Duk Soo KIM ; Hye Lim JUNG ; Moon Soo PARK ; Soo Hee PARK ; Jinmi LEE ; Won Young LEE ; Jung Yeon SHIM
Korean Journal of Pediatrics 2013;56(4):151-158
PURPOSE: We investigated the mRNA levels of peroxisome proliferator-activated receptor (PPAR)-alpha, PPAR-gamma, adipokines, and cytokines in the lung tissue of lean and obese mice with and without ovalbumin (OVA) challenge, and the effect of rosiglitazone, a PPAR-gamma agonist. METHODS: We developed 6 mice models: OVA-challenged lean mice with and without rosiglitazone; obese mice with and without rosiglitazone; and OVA-challenged obese mice with and without rosiglitazone. We performed real-time polymerase chain reaction for leptin, leptin receptor, adiponectin, vascular endothelial growth factor (VEGF), tumor necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta, PPAR-alpha and PPAR-gamma from the lung tissue and determined the cell counts and cytokine levels in the bronchoalveolar lavage fluid. RESULTS: Mice with OVA challenge showed airway hyperresponsiveness. The lung mRNA levels of PPARalpha and PPAR-gamma increased significantly in obese mice with OVA challenge compared to that in other types of mice and decreased after rosiglitazone administeration. Leptin and leptin receptor expression increased in obese mice with and without OVA challenge and decreased following rosiglitazone treatment. Adiponectin mRNA level increased in lean mice with OVA challenge. Lung VEGF, TNF-alpha, and TGF-beta mRNA levels increased in obese mice with and without OVA challenge compared to that in the control mice. However, rosiglitazone reduced only TGF-beta expression in obese mice, and even augmented VEGF expression in all types of mice. Rosiglitazone treatment did not reduce airway responsiveness, but increased neutrophils and macrophages in the bronchoalveolar lavage fluid. CONCLUSION: PPAR-alpha and PPAR-gamma expressions were upregulated in the lung tissue of OVA-challenged obese mice however, rosiglitazone treatment did not downregulate airway inflammation in these mice.
Adipokines
;
Adiponectin
;
Animals
;
Bronchoalveolar Lavage
;
Cell Count
;
Cytokines
;
Inflammation
;
Leptin
;
Lung
;
Macrophages
;
Mice
;
Mice, Obese
;
Neutrophils
;
Obesity
;
Ovalbumin
;
Ovum
;
Peroxisome Proliferator-Activated Receptors
;
Peroxisomes
;
PPAR alpha
;
Real-Time Polymerase Chain Reaction
;
Receptors, Leptin
;
RNA, Messenger
;
Thiazolidinediones
;
Transforming Growth Factor beta
;
Transforming Growth Factors
;
Tumor Necrosis Factor-alpha
;
Vascular Endothelial Growth Factor A
3.Increased Prevalence of H1N1-Induced Severe Lower Respiratory Tract Diseases in Children With Atopic Sensitization.
Yun Ji KIM ; Seung Lok RYU ; Sun Hee JUNG ; Jae Won SHIM ; Deok Soo KIM ; Hye Lim JUNG ; Moon Soo PARK ; Jung Yeon SHIM
Allergy, Asthma & Immunology Research 2012;4(5):277-283
PURPOSE: Viral infection is the most common aggravating factor for childhood asthma. Asthma may be a risk factor for severe respiratory symptoms in children with lower respiratory tract infections of viral etiology. Influenza A infection enhances Th2-polarization to house dust mites during the acute phase and leads to lung dysfunction in a mouse model. However, there are no data on the relationship between atopic sensitization and H1N1 (Influenza A) infection in humans. To investigate whether atopic sensitization is associated with the severity of H1N1 pneumonia, we compared clinical features and the atopic sensitization rate between children with and without H1N1 infection. METHODS: Using reverse transcription-polymerase chain reactions, we investigated H1N1 virus infection in 214 children who were hospitalized with high fever and respiratory symptoms from September 2009 to February 2010. We also performed immunoassays for total and specific IgEs to six common aeroallergens. Atopy was defined as positivity for more than one specific IgE. The clinical severity of pneumonia was evaluated based on intensive care unit admission, oxygen therapy, steroid therapy, and atelectasis. RESULTS: There were 70 H1N1-positive children, 42.9% of whom had pneumonia. Children with H1N1 infection were older and had a higher prevalence of atopic sensitization and pneumonia compared with H1N1-negative children. The rate of atelectasis was higher in children with H1N1 pneumonia than in children with non-H1N1 pneumonia. Among children with H1N1 viral infection, those with atopic sensitization had a higher prevalence of intensive care unit admission and oxygen therapy, and a longer duration of hospitalization than non-atopic children. There were no differences between atopic and non-atopic children without H1N1 viral infection. CONCLUSIONS: The prevalence of H1N1-induced severe lower respiratory tract diseases is higher in children with atopic sensitization.
Animals
;
Asthma
;
Child
;
Fever
;
Hospitalization
;
Humans
;
Immunoassay
;
Immunoglobulin E
;
Influenza A Virus, H1N1 Subtype
;
Influenza, Human
;
Intensive Care Units
;
Lung
;
Mice
;
Oxygen
;
Pneumonia
;
Prevalence
;
Pulmonary Atelectasis
;
Pyroglyphidae
;
Respiratory System
;
Respiratory Tract Diseases
;
Respiratory Tract Infections
;
Risk Factors